BRIEF-Syremis Therapeutics Launches With $165M for Mental‑Health Medicines

Reuters
Dec 18, 2025
BRIEF-Syremis <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Launches With $165M for Mental‑Health Medicines

Dec 18 (Reuters) -

  • SYREMIS THERAPEUTICS LAUNCHES WITH $165M TO DEVELOP BEST-IN-CLASS MEDICINES FOR MENTAL HEALTH CONDITIONS

  • SYREMIS THERAPEUTICS: SERIES A CO-LED BY DEXCEL PHARMA & THIRD ROCK VENTURES, PARTICIPATION FROM BAIN CAPITAL LIFE SCIENCES, GOOGLE VENTURES & OTHERS

Source text: ID:nBw4ynLPja

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10